Research use only · Not for human or veterinary use
Each blend vial ships with structural data and lot identifiers for both peptides, plus a single Certificate of Analysis documenting per-component purity and the blended composition. Pre-mixed for the bench. Both peptides are synthesized via solid-phase peptide synthesis (SPPS), purified independently by reverse-phase HPLC, and combined in a single vial at a verified ratio. Mass spectrometry confirms identity for each component, and sterility plus endotoxin testing applies to the final blend.
BPC-157 is a 15-amino-acid sequence isolated from a partial fragment of a protein found in human gastric juice. In academic literature it is referred to as Body Protection Compound 157. Most cited research originates from the Sikiric group at the University of Zagreb. Documented preclinical investigation spans soft-tissue signaling, gastric mucosal integrity, vascular pathways, and the nitric oxide system.
TB-500 is a synthetic peptide based on the active region of thymosin β4 (Tβ4), a naturally occurring 43-amino-acid protein first isolated from the thymus gland. Tβ4 is one of the most-studied actin-sequestering proteins in the human body. Documented preclinical investigation spans tissue regeneration, cardiac repair models, ocular surface healing, and inflammatory regulation.
Both compounds are most-cited alongside investigations of angiogenesis, actin cytoskeletal remodeling, and tissue regeneration pathways in animal models. Neither has been approved by the FDA for any therapeutic indication. Both remain classified as research compounds.
Each blend vial ships with structural data and lot identifiers for both peptides, plus a single Certificate of Analysis documenting per-component purity and the blended composition. Pre-mixed for the bench. Both peptides are synthesized via solid-phase peptide synthesis (SPPS), purified independently by reverse-phase HPLC, and combined in a single vial at a verified ratio. Mass spectrometry confirms identity for each component, and sterility plus endotoxin testing applies to the final blend.
BPC-157 is a 15-amino-acid sequence isolated from a partial fragment of a protein found in human gastric juice. In academic literature it is referred to as Body Protection Compound 157. Most cited research originates from the Sikiric group at the University of Zagreb. Documented preclinical investigation spans soft-tissue signaling, gastric mucosal integrity, vascular pathways, and the nitric oxide system.
TB-500 is a synthetic peptide based on the active region of thymosin β4 (Tβ4), a naturally occurring 43-amino-acid protein first isolated from the thymus gland. Tβ4 is one of the most-studied actin-sequestering proteins in the human body. Documented preclinical investigation spans tissue regeneration, cardiac repair models, ocular surface healing, and inflammatory regulation.
Both compounds are most-cited alongside investigations of angiogenesis, actin cytoskeletal remodeling, and tissue regeneration pathways in animal models. Neither has been approved by the FDA for any therapeutic indication. Both remain classified as research compounds.
Stable Gastric Pentadecapeptide BPC 157 in the Treatment of Colitis and Ischemia and Reperfusion
PubMed · PubMed · 25869572Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development
PubMed · PubMed · 22489197At Revvd Research, quality comes first. Our peptides are produced using advanced manufacturing processes and verified through comprehensive testing protocols to deliver dependable results for research applications.
Produced
50mg / 10mg / 10mg per vial
10mg / vial
5mg / 5mg per vial
5mg / 5mg per vial
Featured Collection – Premium purity compounds crafted with consistency, precision, and quality in mind.
30-day money back · Free shipping over $150 · 2-day shipping
